Open at the publisher →
In force since 2025-04-06, as the publisher states.
Copy read on 2026-11-10. The page it was read from
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.
sha256 22191a9d57557348c48f1a6f5e357b8f2c6a5abe1e8e4cb4a2347b32334ba574
6 provisions
Title and introductory text
2025 No. 291
PUBLIC HEALTH, ENGLAND
The Health Protection (Notification) (Amendment) Regulations 2025
Made
5th March 2025
Laid before Parliament
7th March 2025
Coming into force
6th April 2025
The Secretary of State makes these Regulations in exercise of the powers conferred by sections 45C(1), (2) and (3)(a), 45F(2)(a) and (b), and 45P(2) of the Public Health (Control of Disease) Act 1984.
In accordance with section 45Q(3) of that Act, the Secretary of State is of the opinion that these Regulations do not contain any provision made by virtue of section 45C(3)(c) of the Act which imposes or enables the imposition of a special restriction or requirement or any other restriction or requirement which has or would have a significant effect on a person’s rights.
Propose a change1 Citation, commencement, extent and application
(1) These Regulations may be cited as the Health Protection (Notification) (Amendment) Regulations 2025.
(2) These Regulations come into force on 6th April 2025.
(3) These Regulations extend to England and Wales and apply in relation to England only.
Propose a change2 Amendment to the Health Protection (Notification) Regulations 2010
The Health Protection (Notification) Regulations 2010 are amended in accordance with regulations 3 to 5.
Propose a change3 Amendment of regulation 4
In regulation 4 (duty on the operators of diagnostic laboratories to notify the United Kingdom Health Security Agency of causative agents found in human samples and of SARS-CoV-2 or influenza virus tests processed)—
(a) in the heading, after “SARS-CoV-2” insert “, respiratory syncytial virus”;
(b) in paragraph (1A)(b), after “of” insert “respiratory syncytial virus or”;
(c) in paragraph (2)(ba), after “SARS-CoV-2” insert “, respiratory syncytial virus”.
Propose a change4 Amendment of Schedule 1
In Schedule 1 (Notifiable Diseases), at the appropriate alphabetical place insert—
Acute flaccid paralysis or acute flaccid myelitis (AFP or AFM)
Chickenpox (varicella)
Congenital syphilis
Creutzfeldt-Jakob disease (CJD)
Disseminated gonococcal infection (DGI)
Influenza of zoonotic origin
Middle East respiratory syndrome coronavirus (MERS)
Neonatal herpes
Propose a change5 Amendment of Schedule 2
In Schedule 2 (Causative Agents), at the appropriate alphabetical place insert—
Candidozyma auris
Echinococcus spp
Middle East respiratory syndrome coronavirus (MERS-CoV)
Non-human influenza A subtypes
Norovirus
Respiratory syncytial virus (RSV)
Tick-borne encephalitis virus (TBEV)
Toxoplasma (congenital toxoplasmosis)
Trichinella spp
Yersinia spp
Propose a change